A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

“…The volume resistivity (ρ_v) decreases with increasing weft and linear densities, too. …”

A Conductive Bamboo Fabric with Controllable Resistance for Tailoring Wearable Sensors by Menghao Li (727830)

“…The volume resistivity (ρ_v) decreases with increasing weft and linear densities, too. …”

Functional annotation of commonly expressed lncRNAs treated with three BET inhibitors. by Mina Baek (12481649)

A large proportion of NSCs redivide within 24 to 72 h. by Valerio Lupperger (9745714)

“…(B–E) Example DLS (yellow arrow) for a labeling interval Δt = 9 h. (F) The DLS proportion is high for Δt = 9 h and decreases rapidly with increasing Δt. …”

Data_Sheet_1_Protein quality of soy and the effect of processing: A quantitative review.pdf by Lisa A. van den Berg (13867319)

“…For all soy products combined, mean DIAAS was 84.5 ± 11.4 and mean PDCAAS was 85.6 ± 18.2. …”

Baseline characteristics. by Nattapat Nitinai (17896679)

“…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”

Subgroup analyses for the primary outcome. by Nattapat Nitinai (17896679)

“…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”

Outcomes. by Nattapat Nitinai (17896679)

“…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”

Trial profile. by Nattapat Nitinai (17896679)

“…The montelukast group exhibited a decreased incidence rate of transaminase elevations (0.7% vs 1.4% per day, HR: 0.48, 95%CI 0.25–0.90, P = 0.023).…”

Utilizing reduction in spheroid counts and/or total nuclear intensity to determine toxic effects of compounds. by Pranjali Beri (14945400)

“…They are indicated appropriately in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0287809#pone.0287809.g004" target="_blank">Fig 4</a>. …”

Mutagenesis of the CXCL10 binding site on <i>L</i>. <i>(L</i>.<i>) major</i> GP63 to <i>L</i>. <i>(V</i>.<i>) panamensis</i> residues reduces CXCL10 cleavage and T cell chemotaxis. by Alejandro L. Antonia (7147739)

“…(L.) major gp63 <i>allele (D463) to the</i> L. (V.) panamensis <i>allele (N463) at the CXCL10 binding site decreases CXCR3</i>^<i>+</i> <i>T cell chemotaxis</i>. …”

Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

“…The reaction of <b>1</b> with pyridine yielded TBA₃[(C₅H₅N)H][γ-SiW₁₀O₃₆{Al(C₅H₅N)}₂(μ-OH)₂]·2H₂O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”

Synthesis of a Dialuminum-Substituted Silicotungstate and the Diastereoselective Cyclization of Citronellal Derivatives by Yuji Kikukawa (1929586)

“…The reaction of <b>1</b> with pyridine yielded TBA₃[(C₅H₅N)H][γ-SiW₁₀O₃₆{Al(C₅H₅N)}₂(μ-OH)₂]·2H₂O (<b>2</b>), and the molecular structure was successfully determined by the X-ray crystallographic analysis. …”

A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone by Georgios Schoretsanitis (4242865)

“…The marketed extended-release formulation has 28% bioavailability. Calculated mean C/D ratios (ng/ml/mg/d) were: 1) 4.09 in 6 studies of 221 non-Korean and non-geriatric adult patients, 2) 2.59 in 2 studies of 100 Korean adult patients, and 3) 6.89 in 1 study with 15 elderly Japanese patients. …”

Comorbidity and progression of late onset Alzheimer’s disease: A systematic review by Miriam L. Haaksma (4003163)

“…<div><p>Background</p><p>Alzheimer’s disease is a neurodegenerative syndrome characterized by multiple dimensions including cognitive decline, decreased daily functioning and psychiatric symptoms. …”

Repetitive stress induces a reduction in sound-evoked activity that develops as the stressor becomes chronic. by Ghattas Bisharat (20706928)

“…(b) Change in activity across sessions per tracked cell in response to 40, 60, and 70 dB white noise. We found a negative slope in most cells especially for mid-intensities, indicating a decrease in activity as the stress becomes chronic (<i>t</i> test for 40 dB <i>p</i> = 0.36, for 60 dB <i>p</i> = 9.3 × 10⁻¹², and for 70 dB <i>p</i> = 0.00750). …”

ABCA1 plays a key role in the inhibition of HCV infection. by Simone Bocchetta (539356)

“…<p>(A) Silencing of ABCA1. Huh7.5 cells were transfected with siRNA that targets ABCA1, or with a control siRNA. …”

<i>Foxj1</i> as a target gene for RFX4. by Ping Xu (122619)

“…<p>(A) qPCR. <i>Foxj1</i> mRNA levels were decreased in E12.5 KO brains, whereas there were no significant differences in <i>Ift172</i>, <i>Thbs</i>, <i>Dync2li1</i>, <i>Rfx2</i>, <i>Rfx3</i> mRNAs, and almost undetectable <i>Rfx4</i> transcripts compared to the controls (P< 0.0001, n = 5). …”

Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

“…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”

Table_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

“…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”